Abstract:The link between cellular exposure to fatty acid species and toxicity phenotypes remains poorly understood. However, structural characterization and functional profiling of human plasma free fatty acids (FFAs) analysis has revealed that FFAs are located either in the toxic cluster or in the cluster that is transcriptionally responsive to lipotoxic stress and creates genetic risk factors. Genome-wide short hairpin RNA screen has identified more than 350 genes modulating lipotoxicity. Hypertrophic adipocytes in obese adipose are both unable to expand further to store excess lipids in the diet and are resistant to the antilipolytic action of insulin. In addition to lipolysis, the inability of packaging the excess lipids into lipid droplets causes circulating fatty acids to reach toxic levels in non-adipose tissues. Deleterious effects of accumulated lipid in non-adipose tissues are known as lipotoxicity. Although triglycerides serve a storage function for long-chain non-esterified fatty acid and their products such as ceramide and diacylglycerols (DAGs), overloading of palmitic acid fraction of saturated fatty acids (SFAs) raises ceramide levels. The excess DAG and ceramide load create harmful effects on multiple organs and systems, inducing chronic inflammation in obesity. Thus, lipotoxic inflammation results in β cells death and pancreatic islets dysfunction. Endoplasmic reticulum stress stimuli induce lipolysis by activating cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and extracellular signal-regulated kinase (Erk) 1/2 signaling in adipocytes. However, palmitic acid-induced endoplasmic reticulum stress-c-Jun N-terminal kinase (JNK)-autophagy axis in hypertrophic adipocytes is a pro-survival mechanism against endoplasmic reticulum stress and cell death induced by SFAs. Endoplasmic reticulum-localized acyl-coenzyme A (CoA): glycerol-3-phosphate acyltransferase (GPAT) enzymes are mediators of lipotoxicity, and inhibiting these enzymes has therapeutic potential for lipotoxicity. Lipotoxicity increases the number of autophagosomes, which engulf palmitic acid, and thus suppress the autophagic turnover. Fatty acid desaturation promotes palmitate detoxification and storages into triglycerides. As therapeutic targets of glucolipotoxicity, in addition to caloric restriction and exercise, there are four different pharmacological approaches, which consist of metformin, glucagon-like peptide 1 (GLP-1) receptor agonists, peroxisome proliferator-activated receptor-gamma (PPARγ) ligands thiazolidinediones, and chaperones are still used in clinical practice. Furthermore, induction of the brown fat-like phenotype with the mixture of eicosapentanoic acid and docosahexaenoic acid appears as a potential therapeutic application for treatment of lipotoxicity.

Lipid droplets and fatty acid‐induced lipotoxicity: in a nutshell

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions

Lipid Droplet–Mitochondria Contacts in Health and Disease

Lipid Droplets: Formation, Degradation, and Their Role in Cellular Responses to Flavivirus Infections

Artificial Lipid Droplets: Novel Effective Biomaterials to Protect Cells against Oxidative Stress and Lipotoxicity

Lipid droplets and cellular lipid flux

Functional interplay of lipid droplets and mitochondria

Recycling the danger via lipid droplet biogenesis after autophagy

Lipid droplet biogenesis and functions in health and disease

Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death

The biogenesis of lipid droplets: Lipids take center stage

Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective

Protein Quality Control and Lipid Droplet Metabolism

Lipid metabolism and signaling in cardiac lipotoxicity

Lipid droplets: a cellular organelle vital in cancer cells

Lipid Droplets, the Central Hub Integrating Cell Metabolism and the Immune System

Lipid droplets in pathogen infection and host immunity

Tapping lipid droplets: A rich fat diet of intracellular bacterial pathogens

Keeping FIT, storing fat: Lipid droplet biogenesis

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Lipid Droplet Contact Sites in Health and Disease